- Home
- MRC vs CDNA Comparison
MRC vs CDNA Comparison
Compare MRC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRC
- CDNA
- Stock Information
- Founded
- MRC 1921
- CDNA 1998
- Country
- MRC United States
- CDNA United States
- Employees
- MRC N/A
- CDNA N/A
- Industry
- MRC Industrial Machinery/Components
- CDNA Medical Specialities
- Sector
- MRC Industrials
- CDNA Health Care
- Exchange
- MRC Nasdaq
- CDNA Nasdaq
- Market Cap
- MRC 1.1B
- CDNA 1.0B
- IPO Year
- MRC 2012
- CDNA 2014
- Fundamental
- Price
- MRC $13.21
- CDNA $20.51
- Analyst Decision
- MRC Strong Buy
- CDNA Buy
- Analyst Count
- MRC 3
- CDNA 6
- Target Price
- MRC $15.67
- CDNA $30.33
- AVG Volume (30 Days)
- MRC 1.2M
- CDNA 908.5K
- Earning Date
- MRC 08-05-2025
- CDNA 07-30-2025
- Dividend Yield
- MRC N/A
- CDNA N/A
- EPS Growth
- MRC N/A
- CDNA N/A
- EPS
- MRC N/A
- CDNA 1.07
- Revenue
- MRC $2,946,000,000.00
- CDNA $346,421,000.00
- Revenue This Year
- MRC $4.95
- CDNA $13.31
- Revenue Next Year
- MRC $6.80
- CDNA $15.46
- P/E Ratio
- MRC N/A
- CDNA $17.91
- Revenue Growth
- MRC N/A
- CDNA 25.92
- 52 Week Low
- MRC $9.23
- CDNA $14.09
- 52 Week High
- MRC $15.59
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- MRC 51.96
- CDNA 62.23
- Support Level
- MRC $12.78
- CDNA $18.37
- Resistance Level
- MRC $13.54
- CDNA $19.84
- Average True Range (ATR)
- MRC 0.51
- CDNA 0.78
- MACD
- MRC -0.05
- CDNA -0.00
- Stochastic Oscillator
- MRC 19.32
- CDNA 84.56
About MRC MRC Global Inc.
MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.